FDA Inspection 1134613 — Belleair Research Center
The FDA completed an inspection of Belleair Research Center on December 17, 2020 in Pinellas Park, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 17, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pinellas Park, FL (United States)
Additional Details
Clinical BA/BE